About
CEVR Team
Careers
Read for the Registry
Contact Us
News & Events
News
Events
Publications
Projects
Databases
CEA Registry
GH CEA Registry
SPEC Database
Sponsorship
Sponsor login
Contact Us
News & Events
News
CEVR Fall 2026 Newsletter
Read CEVR's Fall 2026 Newsletter....
Webinar recording: Strengthening post-approval evidence for accelerated approval drugs
Link to webinar recording: https://tuftsmedicine.zoom.us/......
New Publication: Can Real-World Evidence Reliably Fill Evidence Gaps In Accelerated Approval?
Date: October 13, 2026 Journal: Health Affairs Forefront Citation: Neumann PJ, Hatfield GM, Lin P, Manandhar T, Tunis S. Can Real-World Evidence Relia...
View All News Items
Events
CEVR Health Policy Seminar with Bill Padula PhD
The SPEC team is heading to AMCP Nexus
Join us for CEVR's next webinar on "Strengthening post-approval evidence for accelerated approval drugs"
View All Events
Publications
ISPOR Europe 2026
Comparative Analysis of Oncology Therapy Approvals in the U.S. and Most Favored Nation Countries
AMCP Nexus 2026
Variation in step therapy for commercial plan coverage of rheumatoid arthritis therapies
AMCP Nexus 2026
Do prices and doses differ for initial and follow-on indications? An analysis of multi-indication orphan drugs
Health Affairs Forefront
Can Real-World Evidence Reliably Fill Evidence Gaps In Accelerated Approval?
AMCP Nexus 2026
US Commercial Health Plan Step-Therapy Requirements for Ranibizumab Products, 2017–2025
Health Affairs Forefront
When Negotiated Prices Become The Benchmark: Prior MFPs And The Vanishing Role Of Value
ISPOR 2026 (Poster Presentation)
Comparative Analysis of Oncology Therapy Approvals in the U.S. and Most Favored Nation Countries
PharmacoEconomics
Value of Knowing the Risk of Developing a Neurodegenerative Disease: A Discrete Choice Experiment
JAMA Dermatology
Variation in Coverage of Atopic Dermatitis Therapies Across Commercial Payers
View All Publications
